Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
June 13, 2024 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Announces Collaboration with Novo Nordisk in Diabetes

Biosplice enters into a pre-clinical collaboration with Novo Nordisk to develop inhibitors of DYRK for diabetes
November 17, 2021 09:15 ET | Source: Biosplice Therapeutics, Inc.

First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial in Oncology

SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major...